1. Home
  2. LEE vs VIGL Comparison

LEE vs VIGL Comparison

Compare LEE & VIGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEE
  • VIGL
  • Stock Information
  • Founded
  • LEE 1890
  • VIGL 2020
  • Country
  • LEE United States
  • VIGL United States
  • Employees
  • LEE N/A
  • VIGL N/A
  • Industry
  • LEE Newspapers/Magazines
  • VIGL Biotechnology: Pharmaceutical Preparations
  • Sector
  • LEE Consumer Discretionary
  • VIGL Health Care
  • Exchange
  • LEE Nasdaq
  • VIGL Nasdaq
  • Market Cap
  • LEE 90.6M
  • VIGL 89.3M
  • IPO Year
  • LEE N/A
  • VIGL 2022
  • Fundamental
  • Price
  • LEE $12.17
  • VIGL $2.73
  • Analyst Decision
  • LEE
  • VIGL Strong Buy
  • Analyst Count
  • LEE 0
  • VIGL 5
  • Target Price
  • LEE N/A
  • VIGL $21.00
  • AVG Volume (30 Days)
  • LEE 30.1K
  • VIGL 2.6M
  • Earning Date
  • LEE 02-06-2025
  • VIGL 03-25-2025
  • Dividend Yield
  • LEE N/A
  • VIGL N/A
  • EPS Growth
  • LEE N/A
  • VIGL N/A
  • EPS
  • LEE N/A
  • VIGL N/A
  • Revenue
  • LEE $600,264,000.00
  • VIGL N/A
  • Revenue This Year
  • LEE N/A
  • VIGL N/A
  • Revenue Next Year
  • LEE N/A
  • VIGL N/A
  • P/E Ratio
  • LEE N/A
  • VIGL N/A
  • Revenue Growth
  • LEE N/A
  • VIGL N/A
  • 52 Week Low
  • LEE $7.57
  • VIGL $1.49
  • 52 Week High
  • LEE $19.63
  • VIGL $6.06
  • Technical
  • Relative Strength Index (RSI)
  • LEE 39.55
  • VIGL 71.47
  • Support Level
  • LEE $11.87
  • VIGL $2.22
  • Resistance Level
  • LEE $13.69
  • VIGL $2.53
  • Average True Range (ATR)
  • LEE 0.90
  • VIGL 0.29
  • MACD
  • LEE 0.03
  • VIGL 0.08
  • Stochastic Oscillator
  • LEE 27.12
  • VIGL 80.47

About LEE Lee Enterprises Incorporated

Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high-quality, trusted, intensely local news, information, advertising, and marketing services. The product portfolio of the company includes digital subscription platforms, daily, weekly, and monthly newspapers, and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and content and advertising are available in real-time through the websites and mobile apps.

About VIGL Vigil Neuroscience Inc.

Vigil Neuroscience Inc is a microglia-focused therapeutics company treating both rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel cells of the brain's immune system. It is utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities to rapidly deliver precision-based therapies to improve the lives of patients and families. Its clinical candidate, iluzanebart, is currently being studied in IGNITE, a Phase 2 PoC trial and the first-ever interventional trial in ALSP patients. The company is also developing VG-3927, an orally available small molecule TREM2 agonist for the treatment of common neurodegenerative diseases associated with microglial dysfunction.

Share on Social Networks: